Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
600329
Rank in Stocks
#4374
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its... Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its subsidiaries, primarily manufactures and markets traditional Chinese medicine, Western pharmaceuticals, and various healthcare products within the People's Republic of China. Its business activities are structured into two distinct divisions: Chinese Medicine and Western Medicine. The company's operations extend beyond its core offerings to include the production and distribution of Chinese, Western, and biological pharmaceutical items. It also engages in the wholesale and retail trade of medicines, biochemical pharmaceutical products, and everyday consumer goods, in addition to managing hospitals. Furthermore, Tianjin Pharmaceutical Da Ren Tang provides a comprehensive suite of services such as logistics, inventory management, equipment installation, and drug processing. It also offers pharmaceutical inspection, testing, and advisory services. In terms of its commercial model, the company supplies its proprietary branded medicinal products directly to wholesalers. Conversely, it acquires pharmaceuticals marketed under other brands from distributors, subsequently reselling these to other wholesale clients. Established in 1992 and based in Tianjin, People's Republic of China, the company was previously known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited before adopting its current name in May 2022.
Share Price
$6.17
Market Cap
$3.52B
Change (1 day)
-0.05%
Change (1 year)
-1.86%
Country
CN
Trade Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
Category
Healthcare
Number of shares outstanding for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
Number of shares outstanding as of October 2026: 0
According to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of October 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329) from 2001 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2025 | 769.32M | -0.11% |
| 2024 | 770.16M | -0.09% |
| 2023 | 770.87M | 0.26% |
| 2022 | 768.87M | 0.00% |
| 2021 | 768.87M | 0.00% |
| 2020 | 768.87M | 0.00% |
| 2019 | 768.87M | 0.00% |
| 2018 | 768.87M | 0.13% |
| 2017 | 767.87M | -0.13% |
| 2016 | 768.87M | 2.19% |
| 2015 | 752.40M | 0.94% |
| 2014 | 745.42M | 1.71% |
| 2013 | 732.90M | -0.35% |
| 2012 | 735.50M | -1.99% |
| 2011 | 750.45M | 2.35% |
| 2010 | 733.22M | -0.46% |
| 2009 | 736.62M | 0.37% |
| 2008 | 733.90M | -0.34% |
| 2007 | 736.38M | 0.01% |
| 2006 | 736.29M | 0.00% |
| 2005 | 736.29M | 0.00% |
| 2004 | 736.29M | 0.00% |
| 2003 | 736.29M | 0.00% |
| 2002 | 736.29M | 0.00% |
| 2001 | 736.29M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | - |
IN
|
